Roger L. Waite

1.3k citations

29 papers · 756 indexed · h-index 18

Cellular and Molecular Neuroscience top 5%
Psychiatry and Mental health top 5%
Pharmacology top 5%
Cognitive Neuroscience top 10%
Physiology

Co-authors: Thomas J.H. Chen Eric R. Braverman Kenneth Blum Bernard W. Downs Mallory Kerner Seth H. Blum John Giordano Marlene Oscar‐Berman
Topics: Neurotransmitter Receptor Influence on Behavior (10 papers)Attention Deficit Hyperactivity Disorder (6 papers)Pain Mechanisms and Treatments (5 papers)
Cited by: Cellular and Molecular Neuroscience Psychiatry and Mental health Behavioral Neuroscience
Journals: Journal of Orthopaedic Research®Molecular Neurobiology BMC Musculoskeletal Disorders
Partner nations: United States Taiwan Spain

In The Last Decade

Roger L. Waite

27 papers receiving 699 citations

Peers

Countries citing papers authored by Roger L. Waite

Since Specialization

Citations

This map shows the geographic impact of Roger L. Waite's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger L. Waite with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger L. Waite more than expected).

Fields of papers citing papers by Roger L. Waite

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger L. Waite. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger L. Waite. The network helps show where Roger L. Waite may publish in the future.

Co-authorship network of co-authors of Roger L. Waite

This figure shows the co-authorship network connecting the top 25 collaborators of Roger L. Waite. A scholar is included among the top collaborators of Roger L. Waite based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger L. Waite. Roger L. Waite is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Hypothesizing “Reward” Gene Polymorphisms May Predict High Rates of Injury and Addiction in the Workforce: A Nutrient and Electrotherapeutic Based Solution 2014 ·Health ·Kenneth Blum,(unknown),Roger L. Waite,Seth H. Blum,Kristina Dushaj,Margaret Madigan,Eric R. Braverman,(unknown)	1
2	Hypothesizing repetitive paraphilia behavior of a medication refractive Tourette's syndrome patient having rapid clinical attenuation with KB220Z-nutrigenomic amino-acid therapy (NAAT) 2013 ·Journal of Behavioral Addictions ·Thomas McLaughlin,Marlene Oscar‐Berman,Thomas Simpatico,John Giordano,Simon Jones,Debmalya Barh,William B. Downs,Roger L. Waite,Margaret Madigan,Kristina Dushaj,(unknown),Eric R. Braverman,David K. Han,Kenneth Blum	20
3	Neuropsychopharmacology and Neurogenetic Aspects of Executive Functioning: Should Reward Gene Polymorphisms Constitute a Diagnostic Tool to Identify Individuals at Risk for Impaired Judgment? 2012 ·Molecular Neurobiology ·Abdalla Bowirrat,Thomas J.H. Chen,Marlene Oscar‐Berman,Margaret Madigan,(unknown),John Bailey,Eric R. Braverman,Mallory Kerner,John Giordano,Siobhan Morse,Bernard W. Downs,Roger L. Waite,(unknown),Zaher Armaly,Kenneth Blum	22
4	Neurogenetics and Clinical Evidence for the Putative Activation of the Brain Reward Circuitry by a Neuroadaptagen: Proposing an Addiction Candidate Gene Panel Map 2011 ·Journal of Psychoactive Drugs ·Thomas J.H. Chen,Kenneth Blum,Amanda LC Chen,Abdalla Bowirrat,William B. Downs,(unknown),Roger L. Waite,John Bailey,Mallory Kerner,(unknown),Neil Majmundar,John Giordano,(unknown),David Miller,(unknown),Eric R. Braverman	35
5	Neuro-psychopharmacogenetics and Neurological Antecedents of Posttraumatic Stress Disorder: Unlocking the Mysteries of Resilience and Vulnerability 2010 ·Current Neuropharmacology ·Abdalla Bowirrat,Thomas J.H. Chen,Kenneth Blum,Margaret Madigan,John Bailey,(unknown),Bernard W. Downs,Eric R. Braverman,Radi Shahien,Roger L. Waite,Mallory Kerner,John Giordano,(unknown),Marlene Oscar‐Berman,Mark S. Gold	45
6	Overcoming qEEG Abnormalities and Reward Gene Deficits during Protracted Abstinence in Male Psychostimulant and Polydrug Abusers Utilizing Putative Dopamine D₂Agonist Therapy: Part 2 2010 ·Postgraduate Medicine ·Kenneth Blum,Thomas J.H. Chen,Siobhan Morse,John Giordano,(unknown),James T. Thompson,(unknown),Andrew Smolen,Joel F. Lubar,Eric Stice,Bernard W. Downs,Roger L. Waite,Margaret Madigan,Mallory Kerner,(unknown),Eric R. Braverman	71
7	Repetitive H-Wave® device stimulation and program induces significant increases in the range of motion of post operative rotator cuff reconstruction in a double-blinded randomized placebo controlled human study 2009 ·BMC Musculoskeletal Disorders ·Kenneth Blum,Amanda LC Chen,Thomas J.H. Chen,Roger L. Waite,Bernard W. Downs,Eric R. Braverman,Mallory Kerner,(unknown),Nicholas A. DiNubile	17
8	Do dopaminergic gene polymorphisms affect mesolimbic reward activation of music listening response? Therapeutic impact on Reward Deficiency Syndrome (RDS) 2009 ·Medical Hypotheses ·Kenneth Blum,Thomas J.H. Chen,(unknown),Margaret Madigan,Bernard W. Downs,Roger L. Waite,Eric R. Braverman,Mallory Kerner,Abdalla Bowirrat,John Giordano,(unknown),Mark S. Gold	40
9	Preliminary investigation of plasma levels of sex hormones and human growth factor(s), and P300 latency as correlates to cognitive decline as a function of gender 2009 ·BMC Research Notes ·Eric R. Braverman,Thomas J.H. Chen,Amanda LC Chen,Mallory Kerner,Howard Tung,Roger L. Waite,John Schoolfield,Kenneth Blum	10
10	H‐Wave® induces arteriolar vasodilation in rat striated muscle via nitric oxide‐mediated mechanisms 2009 ·Journal of Orthopaedic Research® ·Thomas L. Smith,Kenneth Blum,Michael F. Callahan,Nicholas A. DiNubile,Thomas J.H. Chen,Roger L. Waite	10
11	Nutrigenomic targeting of carbohydrate craving behavior: Can we manage obesity and aberrant craving behaviors with neurochemical pathway manipulation by Immunological Compatible Substances (nutrients) using a Genetic Positioning System (GPS) Map? 2009 ·Medical Hypotheses ·Bernard W. Downs,Amanda LC Chen,Thomas J.H. Chen,Roger L. Waite,Eric R. Braverman,Mallory Kerner,(unknown),Patrick Rhoades,Thomas J. Prihoda,Tomás Palomo,Marlene Oscar‐Berman,Jeffrey Reinking,Seth H. Blum,Nicholas A. DiNubile,(unknown),Kenneth Blum	21
12	LG839: Anti-obesity effects and polymorphic gene correlates of reward deficiency syndrome 2008 ·Advances in Therapy ·Kenneth Blum,Amanda LC Chen,Thomas J.H. Chen,Patrick Rhoades,Thomas J. Prihoda,Bernard W. Downs,Roger L. Waite,(unknown),Eric R. Braverman,(unknown),Vanessa Arcuri,Mallory Kerner,Seth H. Blum,Tomás Palomo	41
13	The H-Wave® device is an effective and safe non-pharmacological analgesic for chronic pain: a meta-analysis 2008 ·Advances in Therapy ·Kenneth Blum,Amanda LC Chen,Thomas J.H. Chen,Thomas J. Prihoda,John Schoolfield,Nicholas A. DiNubile,Roger L. Waite,Vanessa Arcuri,Mallory Kerner,Eric R. Braverman,Patrick Rhoades,Howard Tung	17
14	Activation instead of blocking mesolimbic dopaminergic reward circuitry is a preferred modality in the long term treatment of reward deficiency syndrome (RDS): a commentary 2008 ·Theoretical Biology and Medical Modelling ·Kenneth Blum,(unknown),Thomas J.H. Chen,Eric R. Braverman,Jeffrey Reinking,Seth H. Blum,(unknown),Bernard W. Downs,Roger L. Waite,(unknown),Thomas J. Prihoda,Mallory Kerner,Tomás Palomo,David E. Comings,Howard Tung,Patrick Rhoades,Marlene Oscar‐Berman	112
15	Hypothesizing that brain reward circuitry genes are genetic antecedents of pain sensitivity and critical diagnostic and pharmacogenomic treatment targets for chronic pain conditions 2008 ·Medical Hypotheses ·Amanda LC Chen,Thomas J.H. Chen,Roger L. Waite,Jeffrey Reinking,Howard Tung,Patrick Rhoades,Bernard W. Downs,Eric R. Braverman,(unknown),Mallory Kerner,Seth H. Blum,Nicholas A. DiNubile,David E. Smith,Marlene Oscar‐Berman,Thomas J. Prihoda,(unknown),David O’Brien,(unknown),Kenneth Blum	36
16	A short term pilot open label study to evaluate efficacy and safety of LG839, a customized DNA directed nutraceutical in obesity: Exploring Nutrigenomics 2008 ·Kenneth Blum,Thomas J.H. Chen,(unknown),(unknown),William B. Downs,Roger L. Waite,(unknown),Simon H. Sims,Thomas J. Prihoda,(unknown),Jeffrey Reinking,(unknown),Mallory Kerner,Seth H. Blum,(unknown),Eric R. Braverman	23
17	Gene Narcotic Attenuation Program attenuates substance use disorder, a clinical subtype of reward deficiency syndrome 2007 ·Advances in Therapy ·Thomas J.H. Chen,Kenneth Blum,Roger L. Waite,(unknown),John Schoolfield,(unknown),(unknown),Vanessa Arcuri,(unknown),Seth H. Blum,(unknown),(unknown),Tomás Palomo	25
18	Manipulation of catechol-O-methyl-transferase (COMT) activity to influence the attenuation of substance seeking behavior, a subtype of Reward Deficiency Syndrome (RDS), is dependent upon gene polymorphisms: A hypothesis 2007 ·Medical Hypotheses ·Kenneth Blum,Thomas J.H. Chen,(unknown),Roger L. Waite,Bernard W. Downs,Seth H. Blum,(unknown),Vanessa Arcuri,Eric R. Braverman,Tomás Palomo	42
19	H-wave®, a nonpharmacologic alternative for the treatment of patients with chronic soft tissue inflammation and neuropathic pain: A preliminary statistical outcome study 2006 ·Advances in Therapy ·Kenneth Blum,Nicholas A. DiNubile,Thomas J.H. Chen,Roger L. Waite,John Schoolfield,Manuel Martinez-Pons,Michael F. Callahan,Thomas L. Smith,(unknown),Seth H. Blum,(unknown)	12
20	The H-Wave® small muscle fiber stimulator, a nonpharmacologic alternative for the treatment of chronic soft-tissue injury and neuropathic pain: an extended population observational study 2006 ·Advances in Therapy ·Kenneth Blum,Thomas J.H. Chen,Manuel Martínez Pons,Nicholas A. DiNubile,Roger L. Waite,John Schoolfield,Seth H. Blum,(unknown),Bernard W. Downs,(unknown)	10

About Roger L. Waite

Roger L. Waite is a scholar working on Anesthesiology and Pain Medicine, Behavioral Neuroscience and Cellular and Molecular Neuroscience, having authored 29 papers that have together received 756 indexed citations. Recurring topics across this work include Neurotransmitter Receptor Influence on Behavior (10 papers), Attention Deficit Hyperactivity Disorder (6 papers) and Pain Mechanisms and Treatments (5 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (341 citations), Psychiatry and Mental health (282 citations) and Behavioral Neuroscience (44 citations). Roger L. Waite has collaborated with scholars based in United States, Taiwan and Spain. Frequent co-authors include Thomas J.H. Chen, Eric R. Braverman, Kenneth Blum, Bernard W. Downs, Mallory Kerner, Seth H. Blum, John Giordano, Marlene Oscar‐Berman, Patrick Rhoades and Nicholas A. DiNubile. Their work appears in journals such as Journal of Orthopaedic Research®, Molecular Neurobiology and BMC Musculoskeletal Disorders.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact